“…28 In this blinded trial of bupropion (200 mg/day) versus amantadine (200 mg/day), the bupropion group reported more improvement in desire, arousal, and pleasure. A doubleblind, randomized, placebo-controlled study that was published in favor of bupropion augmentation was later retracted.…”